Matrix metalloproteinase-9: A novel biomarker for monitoring disease activity in patients with chronic urticaria patients?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 4, 2009, Pages 652-656

  Altrichter, S ^a   Boodstein, N ^a   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic urticaria; Mast cells; MMP 9

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B;

ADULT; ARTICLE; CHRONIC URTICARIA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PSORIASIS; SCORING SYSTEM; SYMPTOM;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PSORIASIS; URTICARIA;

EID: 62449230715     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01799.x     Document Type: Article

References (16)

1. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999 29 : 2645 2649.
2. Tanaka A, Matsuda H. IgE crosslinkage of Fcepsilon receptor I induces both production and activation of matrix metalloproteinase-9 in mast cells. Cell Immunol 2004 228 : 66 75.
3. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002 122 : 1543 1552.
4. Devillers AC, van Toorenenbergen AW, Klein Heerenbrink GJ, Muldert PG, Oranje AP. Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study. Clin Exp Dermatol 2007 32 : 311 313.
5. Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003 3 : 363 368.
6. Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G et al. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy 2005 35 : 221 225.
7. Caproni M, Giomi B, Volpi W, Del Bianco E, Fabbri P. Metalloproteinase activity in chronic urticaria. EADV, 16th Congress of the European Academy of Dermatology and Venerology. Vienna, Austria 16-20th May 2007, P1356.
8. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, Zucker S. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 1992 28 : 213 230.
9. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 61 : 316 320.
10. van de Kerkhof PC, Kragballe K, Austad J, Berth-Jones J, Cambazard F, de la Brassinne M et al. Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity. Eur J Dermatol 2006 16 : 167 171.
11. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006 212 : 150 159.
12. Nakashima K, Hirota T, Obara K, Shimizu M, Doi S, Fujita K et al. A functional polymorphism in MMP-9 is associated with childhood atopic asthma. Biochem Biophys Res Commun 2006 344 : 300 307.
13. Tayebjee MH, Lip GY, Blann AD, Macfadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005 115 : 205 210.
14. Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995 33 : 192 198.
15. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 2001 167 : 4008 4016.
16. Tanaka A, Yamane Y, Matsuda H. Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. J Vet Med Sci 2001 63 : 811 813.